Natural Order Acquisition Corp. Common Stock
NOAC
NOAC was delisted on the 10th of November, 2022.
0 hedge funds and large institutions have $0 invested in Natural Order Acquisition Corp. Common Stock in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 61 closing their positions.
100% less funds holding
Funds holding: 61 → 0 (-61)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $169M → $0 (-$169M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 61
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MMA
Mizuho Markets Americas
New York
|
-$11.6M |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$11.3M |
| 3 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
-$10.9M |
| 4 |
HI
HBK Investments
Dallas,
Texas
|
-$8M |
| 5 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$7.96M |
NOAC Hedge Fund Activity: Q4 2022 in Review
0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Natural Order Acquisition Corp. Common Stock (NOAC) for Q4 2022, worth a combined $0 — down 100% from $169M a quarter earlier.
Sellers outnumbered buyers: 61 funds closed out of NOAC and 0 opened new positions — a net loss of 61 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Mizuho Markets Americas, exiting entirely with an estimated $11.6M sold.
- 0 institutional investors held Natural Order Acquisition Corp. Common Stock (NOAC) as of Q4 2022, down from 61 in Q3 2022.
- Funds reported $0 of Natural Order Acquisition Corp. Common Stock stock for Q4 2022, down 100% quarter-over-quarter.
- 0 funds opened new Natural Order Acquisition Corp. Common Stock positions in Q4 2022 and 61 closed out, a net change of -61 holders.
- The largest Natural Order Acquisition Corp. Common Stock seller in Q4 2022 was Mizuho Markets Americas, an estimated $11.6M sold.
Based on aggregated 13F filings for Q4 2022.